Clinical Trial Update: MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study [Phase 4]

View source ↗

Summary

Phase 4 post-market study update assessing HTLV blot 2.4 for HTLV-I and HTLV-II infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Htlv-i Associated Cell Leukemia Lymphoma
• Htlv-i-associated Myelopathy
• Human T-lymphotropic Virus Type Ii Infection
• Human T-lymphotropic Virus Type Infection

Drugs mentioned

• HTLV Blot 2.4 (HTLV Blot 2.4)

Snippet

Sponsor: MP Biomedicals, LLC | Conditions: HTLV-I Infections, HTLV-II Infections | Phase 4 | Status: COMPLETED